Inclusion Criteria:
  -  Clinical diagnosis of Parkinson's disease according to the UK Brain Bank criteria.
  -  Subjects had clinically moderate to advanced severity of disease (Hoehn and Yahr stage
     2 - 4).
  -  Subjects whose medical treatment had been on stable dosage of dopaminomimetics for at least 4 weeks before the study.
  -  Subjects ability to walk with or without assistive device.
Exclusion Criteria:
  -  Subjects had cardiovascular, inflammatory or musculoskeletal problems that could prevent them to participate in an exercise program.
  -  Subjects whose mini mental status examination score was less than 26.